{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/GGAL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-08T11:26:17.638Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9014,"canonical_name":"GRUPO FINANCIERO GALICIA SA","cik":"0001114700","uei":null,"lei":null,"duns":null,"ticker":"GGAL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":16},"count":16,"timeline":[{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — GRUPO FINANCIERO GALICIA SA — 2026-07-13","url_slug":"/sec/cik-0001114700/4/0001213900-26-077729","accession_number":"0001213900-26-077729","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"4","title":"4 — GRUPO FINANCIERO GALICIA SA — 2026-07-09","url_slug":"/sec/cik-0001114700/4/0001213900-26-076871","accession_number":"0001213900-26-076871","importance":30},{"ts":"2026-07-08","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":224000,"price_per_share":5.36,"usd_value":1200640,"security_title":"Class B Ordinary Shares","importance":51.20064},{"ts":"2026-07-08","kind":"sec.insider.224000","reporter":"Moret Silvestre Vila","title":null,"shares":224000,"price_per_share":5.36,"usd_value":1200640,"security_title":"Class B Ordinary Shares","importance":16.20064},{"ts":"2026-07-07","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":175824,"price_per_share":5.46,"usd_value":959999,"security_title":"Class B Ordinary Shares","importance":50.95999904},{"ts":"2026-07-07","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":176,"price_per_share":5.46,"usd_value":961,"security_title":"Class B Ordinary Shares","importance":50.00096096},{"ts":"2026-07-07","kind":"sec.insider.175824","reporter":"Moret Silvestre Vila","title":null,"shares":175824,"price_per_share":5.46,"usd_value":959999,"security_title":"Class B Ordinary Shares","importance":15.95999904},{"ts":"2026-07-02","kind":"sec.filing","form_type":"6-K","title":"6-K — GRUPO FINANCIERO GALICIA SA — 2026-07-02","url_slug":"/sec/cik-0001114700/6-k/0001114700-26-000059","accession_number":"0001114700-26-000059","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"6-K","title":"6-K — GRUPO FINANCIERO GALICIA SA — 2026-07-02","url_slug":"/sec/cik-0001114700/6-k/0001114700-26-000061","accession_number":"0001114700-26-000061","importance":30},{"ts":"2026-07-01","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":100000,"price_per_share":5.11,"usd_value":511000,"security_title":"Class B Ordinary Shares","importance":50.511},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":167791,"price_per_share":5.27,"usd_value":884259,"security_title":"Class B Ordinary Shares","importance":50.88425857},{"ts":"2026-06-30","kind":"sec.filing","form_type":"6-K","title":"6-K — GRUPO FINANCIERO GALICIA SA — 2026-06-30","url_slug":"/sec/cik-0001114700/6-k/0001114700-26-000053","accession_number":"0001114700-26-000053","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"6-K","title":"6-K — GRUPO FINANCIERO GALICIA SA — 2026-06-30","url_slug":"/sec/cik-0001114700/6-k/0001114700-26-000056","accession_number":"0001114700-26-000056","importance":30},{"ts":"2026-06-29","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":10000,"price_per_share":5.25,"usd_value":52500,"security_title":"Class B Ordinary Shares","importance":50.0525},{"ts":"2026-06-26","kind":"sec.insider.p","reporter":"Moret Silvestre Vila","title":"","shares":125000,"price_per_share":5.15,"usd_value":643750,"security_title":"Class B Ordinary Shares","importance":50.64375},{"ts":"2026-05-13","kind":"sec.filing","form_type":"6-K","title":"6-K — GRUPO FINANCIERO GALICIA SA — 2026-05-13","url_slug":"/sec/cik-0001114700/6-k/0001114700-26-000051","accession_number":"0001114700-26-000051","importance":30}]}